OrbiMed Advisors leads Series A round for Clementia Pharmaceuticals
Newton, Mass.-based clinical stage biotech firm Clementia Pharmaceuticals has raised $10 million in Series A funding. OrbiMed Advisors led the round with participation from BDC Venture Capital.
5 January 2015•3 mins read
